Press release 2021 Archives

Latest Posts

Partnering to unlock the true potential of cannabis in medical care

AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

featured

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

featured

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...

Innoplexus wins Horizon Interactive Gold Award for Curia App

Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform

COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston, M.A. and Durham, N.C., May 11, 2021 – Innoplexus, a global leader in AI-based drug discovery and development, and Parexel, a leading global clinical research organization, have expanded the features and functionality of their COVID-19 Clearinghouse platform …

Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform Read More »

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	The cookies are used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is used to store whether or not a user has consented to the use of cookies. It does not store any personal data.

Latest Posts

Partnering to unlock the true potential of cannabis in medical care

27

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

9

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

Category: Press release 2021

Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform

Partnering to unlock the true potential of cannabis in medical care

Partnering to make 100,000s COVID-19 publications searchable

Machine learning as an indispensable tool for Biopharma

Precision medicine and the discovery of biomarkers

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

OncoCoin AG donates for a charity bicycle tour: Tour of Hope

Innoplexus and Innovatrix capital partner to bring about new risk-transfer solutions for the life science industry

WHO WE ARE

WHAT WE OFFER

HOW WE WORK

WHY US

Updates

Frankfurt (Germany)

Pune (India)

Iselin (USA)

Cham (Switzerland)